home / stock / elox / elox short
Short Information | Eloxx Pharmaceuticals Inc. (NASDAQ:ELOX)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 99,139 |
Total Actual Volume | 444,216 |
Short Trends | |
---|---|
Cover Days | 17 |
Short Days | 1 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 4,957 |
Average Short Percentage | 21.31% |
Is there a ELOX Short Squeeze or Breakout about to happen?
See the ELOX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
10-13-2023 | $4.05 | $3.82 | $4.29 | $3.79 | 45,132 | 23,418 | 51.89% |
10-12-2023 | $4.23 | $4.05 | $4.245 | $3.91 | 28,162 | 3,610 | 12.82% |
10-11-2023 | $4.4 | $4.15 | $4.4 | $4.1 | 12,523 | 3,882 | 31% |
10-10-2023 | $4.39 | $4.36 | $4.49 | $4.15 | 10,046 | 1,456 | 14.49% |
10-09-2023 | $4.3 | $4.4 | $4.48 | $4.2119 | 18,097 | 5,502 | 30.4% |
10-06-2023 | $4.46 | $4.32 | $4.53 | $4.2 | 25,935 | 8,270 | 31.89% |
10-05-2023 | $4.74 | $4.51 | $4.74 | $4.51 | 5,037 | 1,179 | 23.41% |
10-04-2023 | $4.66 | $4.58 | $5.09 | $4.5301 | 39,988 | 2,464 | 6.16% |
10-03-2023 | $4.51 | $4.78 | $5.18 | $4.51 | 32,489 | 3,568 | 10.98% |
10-02-2023 | $4.68 | $4.76 | $4.8 | $4.6 | 3,938 | 504 | 12.8% |
09-29-2023 | $4.78 | $4.81 | $5 | $4.69 | 16,515 | 1,594 | 9.65% |
09-28-2023 | $4.99 | $4.63 | $5.0194 | $4.63 | 14,949 | 7,356 | 49.21% |
09-27-2023 | $4.97 | $4.92 | $5.1789 | $4.8992 | 8,909 | 423 | 4.75% |
09-26-2023 | $4.78 | $4.94 | $5.2 | $4.78 | 24,198 | 3,558 | 14.7% |
09-25-2023 | $4.98 | $4.84 | $5.4616 | $4.71 | 16,300 | 4,013 | 24.62% |
09-22-2023 | $4.86 | $5.02 | $5.245 | $4.86 | 11,500 | 4,546 | 39.53% |
09-21-2023 | $5.42 | $4.86 | $5.4899 | $4.66 | 42,914 | 14,582 | 33.98% |
09-20-2023 | $5.4 | $5.53 | $5.62 | $5.3 | 10,406 | 589 | 5.66% |
09-19-2023 | $5.45 | $5.55 | $5.55 | $5.2732 | 20,836 | 955 | 4.58% |
09-18-2023 | $5.99 | $5.46 | $5.99 | $5.26 | 56,342 | 7,670 | 13.61% |
News, Short Squeeze, Breakout and More Instantly...
Eloxx Pharmaceuticals Inc. Company Name:
ELOX Stock Symbol:
NASDAQ Market:
Eloxx Pharmaceuticals Inc. Website:
ELX-02 Granted Orphan Drug Designation (ODD) from U.S. Food and Drug Administration (FDA) for Treatment of Alport Syndrome Pre-Investigational New Drug (IND) Meeting Requested with U.S. FDA for ELX-02 to Discuss Planned next Study In Nonsense Mutation Alport Syndrome Signed Glob...
GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...
Almirall obtains exclusive global rights to develop and commercialize ZKN-013 for the treatment of rare dermatological and other diseases associated with nonsense mutations ZKN-013 is a phase I ready oral therapy designed to overcome nonsense mutations that cause a premature stop codon ...